Longevity
Tirzepatide
5 MG · Research Peptide
$49.00
A research blend combining GHK-Cu and complementary peptides, studied in laboratory settings related to skin and cellular biology.
- 5 mg lyophilized powder per vial
- ≥ 98% purity, HPLC verified
- Cold-chain handled and batch tested
- For laboratory research use only
View Tirzepatide batch Certificates of AnalysisTirzepatide research guideRP-HPLC purity standards guideMass spectrometry testing guideStorage and refrigeration guideReconstitution guideGlossary of analytical terms
Research use only. Not for human consumption.
What is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide with a C20 fatty diacid moiety that acts as a dual GIP and GLP-1 receptor agonist in laboratory studies. Vector E Lab supplies it as a research reference material only, not as a medicine.
| Sequence | 39-residue synthetic backbone with Aib substitutions at positions 2 and 13 and a C20 fatty diacid conjugated at Lys20 |
|---|---|
| Length | 39 amino acids |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.5 g/mol (average) |
| CAS number | 2023788-19-2 |
| Purity specification | ≥ 98.0% by RP-HPLC |
| Research status | Extensively characterised in published clinical literature. Material supplied by Vector E Lab is analytical research-grade reference material and is not a pharmaceutical product. |
| Analytical methods | Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot. |
| Available COA | Lot-specific Certificates of Analysis are published in the Vector E Lab COA library under the product name Tirzepatide. View published certificates |
| Regulatory context | Supplied for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified personnel. Not for human or veterinary use, not for diagnostic procedures, and not a therapeutic product. |
| References |
Analytical specifications
| Purity (RP-HPLC) | ≥ 98.0% by reversed-phase HPLC |
|---|---|
| Fill quantity | 5 MG lyophilized powder per vial |
| Category | Longevity |
| Intended use | Research Use Only (RUO) — in-vitro laboratory research |
Frequently asked questions
- What is Tirzepatide?
- Tirzepatide is a synthetic 39-amino-acid peptide with a C20 fatty diacid moiety that acts as a dual GIP and GLP-1 receptor agonist in laboratory studies. Vector E Lab supplies it as a research reference material only, not as a medicine. Sequence: 39-residue synthetic backbone with Aib substitutions at positions 2 and 13 and a C20 fatty diacid conjugated at Lys20. Molecular weight: 4813.5 g/mol (average). CAS number: 2023788-19-2. Research status: Extensively characterised in published clinical literature. Material supplied by Vector E Lab is analytical research-grade reference material and is not a pharmaceutical product. Analytical methods: Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot.
- What is the purity of Tirzepatide?
- Tirzepatide is released at ≥ 98.0% purity as determined by reversed-phase HPLC (RP-HPLC). Purity is reported per lot on the batch Certificate of Analysis.
- Is a Certificate of Analysis available for Tirzepatide?
- Batch Certificates of Analysis for Vector E Lab research peptides are published in the COA library. Contact support with your lot number if a specific Tirzepatide certificate is not yet listed.
- How is Tirzepatide supplied?
- Each vial contains 5 MG of lyophilized powder, supplied in the Longevity research category for in-vitro laboratory work.
- Can Tirzepatide be used in humans or animals?
- No. Tirzepatide is supplied strictly for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified laboratory personnel. It is not for human or veterinary use, diagnostic procedures, or therapeutic administration.
Related research peptides
